Structures of α-synuclein filaments from human brains with Lewy pathology

Yang Yang, Manuel Schweighauser, Xianjun Zhang, Abhay Kotecha, Alexey G. Murzin, Holly J. Garringer, Patrick W. Cullinane, Yuko Saito, Tatiana Foroud, Thomas T. Warner, Kazuko Hasegawa, Rubén Vidal, Shigeo Murayama, Tamás Révész, Bernardino Ghetti, Masato Hasegawa, Tammaryn Lashley, Sjors H. W. Scheres, Michel GoedertNature 2022 · DOI

TL;DR

Researchers have determined the atomic structures of α-synuclein filaments from human brains affected by Lewy pathology, revealing a distinct "Lewy fold" that differs from previously characterized structures found in Multiple System Atrophy (MSA). This discovery establishes that different neurodegenerative diseases are associated with distinct molecular conformers of α-synuclein, offering new avenues for understanding disease mechanisms and developing targeted therapies.

What Problem Does This Paper Address?

Parkinson's disease (PD) and related disorders like Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB) are characterized by the accumulation of misfolded α-synuclein protein in the form of Lewy bodies and Lewy neurites. While it's known that different synucleinopathies (diseases caused by α-synuclein aggregation) can have distinct pathological features, the precise molecular structures of these protein aggregates in human brains have remained largely elusive. Previously, the authors had determined the structures of α-synuclein filaments from MSA, another synucleinopathy, which showed a different fold. This left open the question of whether the α-synuclein filaments in Lewy body diseases (PD, PDD, DLB) also possess a unique structure and how it compares to the MSA fold. Understanding these structural differences is crucial for deciphering the varying disease mechanisms and for developing specific diagnostic tools and treatments.

Methods

The study employed cryo-electron microscopy (cryo-EM) to determine the atomic structures of α-synuclein filaments. Sarkosyl-insoluble material was extracted from the brain tissues of individuals with PD, PDD, and DLB. These extracted filaments were then subjected to cryo-EM imaging. The researchers utilized helical reconstruction methods to build 3D models of the filaments from the 2D images. They specifically focused on identifying and analyzing twisted filament segments, which allowed for higher-resolution structural determination. The resulting cryo-EM maps were used to build atomic models of the α-synuclein filaments, which were then compared to known structures of α-synuclein filaments from other sources.

Datasets

The study utilized brain tissue samples from individuals diagnosed with:

  • Parkinson's disease (PD)
  • Parkinson's disease dementia (PDD)
  • Dementia with Lewy bodies (DLB)

These samples were used to extract and analyze α-synuclein filaments. No new benchmark datasets were introduced; rather, the study focused on characterizing the structures derived from human patient samples.

Key Insights and Ideas

  • Distinct "Lewy Fold": The α-synuclein filaments from PD, PDD, and DLB share a common, unique structure termed the "Lewy fold." This fold is markedly different from the previously determined MSA fold.
  • Single Protofilament Structure: Unlike the MSA filaments, which are composed of two protofilaments, the Lewy fold is formed by a single protofilament.
  • Implications for Disease Continuum: The shared Lewy fold across PD, PDD, and DLB supports the idea that these diseases represent a continuum, differing primarily in the timing and severity of cognitive and motor symptoms.
  • Structural Basis for Differential Seeding: The distinct structures of Lewy and MSA folds likely explain why different synucleinopathies can propagate and cause different pathologies, and why seed amplification assays can distinguish between them.
  • Potential for Targeted Therapies: Knowing the precise atomic structure of the Lewy fold opens up possibilities for designing drugs that specifically target this conformation, potentially inhibiting its formation or spread.

Key Results

The cryo-EM analysis revealed that α-synuclein filaments from PD, PDD, and DLB are structurally identical and adopt a "Lewy fold." This fold is characterized by a right-handed twist and is formed by residues 31-100 of α-synuclein, arranged into nine β-strands. The highest resolution achieved was 2.2 Å for one of the PDD cases. This structure is distinct from the two types of α-synuclein filaments previously identified in MSA, which are composed of two protofilaments. The study also found that while most filaments were untwisted, a minority (~25%) exhibited a helical twist, enabling their structural determination.

Limitations and Future Work

  • Untwisted Filaments: The study primarily determined the structure of twisted filaments, acknowledging that the structures of the untwisted filaments were not fully resolved. However, evidence suggests they likely adopt the Lewy fold as well.
  • Minority Folds: The possibility of additional, minority folds among untwisted filaments cannot be entirely excluded.
  • Cellular Environment: The study highlights the importance of the cellular environment in dictating α-synuclein fold formation, suggesting that in vitro assembly methods may not fully replicate in vivo structures.
  • Future Directions: The authors suggest further research to:
  • Investigate the role of post-translational modifications and non-proteinaceous densities in fold formation.
  • Develop methods to assemble recombinant α-synuclein into Lewy and MSA folds in vitro.
  • Identify conditions for creating seeded aggregates with structures identical to human brain seeds.
  • Produce animal models that recapitulate the structures of human brain α-synuclein filaments.
  • Explore whether α-synuclein filaments in other conditions associated with Lewy pathology (e.g., incidental Lewy body disease, peripheral nervous system pathology) share the same Lewy fold.
  • Use this structural knowledge for developing specific biomarkers and mechanism-based therapies.

Summary updated

BibTeX
@inproceedings{yang2022structures,
  author = {Yang Yang and Yue‐De Yang and Manuel Schweighauser and Xianjun Zhang and Abhay Kotecha and Alexey G. Murzin and Holly J. Garringer and Patrick W. Cullinane and Yuko Saito and Tatiana Foroud and Thomas T. Warner and Kazuko Hasegawa and Rubén Vidal and Shigeo Murayama and Tamás Révész and Bernardino Ghetti and Masato Hasegawa and Tammaryn Lashley and Sjors H. W. Scheres and Michel Goedert},
  title = {{Structures of α-synuclein filaments from human brains with Lewy pathology}},
  booktitle = {Nature},
  year = {2022},
  doi = {10.1038/s41586-022-05319-3},
}
Figure